Affinity Asset Advisors’s Spyre Therapeutics SYRE Stock Holding History

Affinity Asset Advisors’s Portfolio SYRE Stock Details SYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$9.08M	Buy
2025 Q1	$7.77M	Sell
2024 Q4	$19.2M	Buy
2024 Q3	$14.7M	Sell
2024 Q2	$12.1M	Buy
2024 Q1	$15.6M	Sell
2023 Q4	$11.1M	Buy
2023 Q3	$2.97M	Buy
2023 Q2	$2.21M	Buy